Thursday Nov 21
Times of Oman
Migraine is the most common cause of benign recurrent vascular headache. It affects approximately 15 per cent of women and six per cent of men.
GlaxoSmithKline says data supports Cervarix two-dose schedule for young girls
On the Fly: Periodicals Wrap-Up WALL STREET JOURNAL: Investors are stampeding into IPOs at the fastest clip since the financial crisis, fueling a frenzy in the shares of newly listed companies that echoes the technology-stock craze of the late 1990s, the Wall Street Journal reports...BlackBerry's future may become clearer as soon as today when a ... (more)
Migraine medication Imitrex recalled by Health Canada
Health Canada says needles in the affected lots may be protruding through their protective plastic shields and are no longer sterile.
Media Advisory: GSK Recalls Two Lots of Migraine Medication: IMITREX Injection
GlaxoSmithKline Inc., in consultation with Health Canada, is voluntarily recalling two lots of "IMITREX Injection", a migraine medication packaged in pre-filled syringes with an accompanying sterile needle for injection.